Publications (14)

2023

  1. Anticipatory Antifungal Treatment in Critically Ill Patients with SARS-CoV-2 Pneumonia

    Journal of Fungi, Vol. 9, Núm. 3

2022

  1. Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project

    Microbiology spectrum, Vol. 10, Núm. 4, pp. e0005122

2021

  1. The prognostic value of toxin B and binary toxin in Clostridioides difficile infection

    Gut Microbes, Vol. 13, Núm. 1

  2. Loss of smell and taste can accurately predict COVID-19 infection: A machine-learning approach

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-17

  3. Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection

    Diagnostic Microbiology and Infectious Disease, Vol. 101, Núm. 4

2020

  1. Sample pooling for SARS-CoV-2 RT-PCR screening

    Clinical Microbiology and Infection, Vol. 26, Núm. 12, pp. 1687.e1-1687.e5

  2. Evolution of the antimicrobial resistance rates in clinical isolates of Pseudomonas aeruginosa causing invasive infections in the south of Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 150-154

2017

  1. Spondylodiscitis due to Aerococcus urinae infection in an elderly immunocompetent patient

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 10, pp. 682-684

  2. A cost-saving strategy for processing isolated uropathogens in community-acquired urinary tract infections

    Journal of Microbiological Methods, Vol. 139, pp. 130-134

2016

  1. Synthesis, antibacterial and antifungal activities of naphthoquinone derivatives: a structure–activity relationship study

    Medicinal Chemistry Research, Vol. 25, Núm. 6, pp. 1274-1285

2013

  1. Soy isoflavones and their relationship with microflora: Beneficial effects on human health in equol producers

    Phytochemistry Reviews, Vol. 12, Núm. 4, pp. 979-1000

  2. Annual fluctuation in the rate of resistant bacteria isolated as an indicator in the control of hospital-acquired infections

    Infection Control and Hospital Epidemiology

2009

  1. Protective effect of curcumin, a Curcuma longa constituent, in early colonic inflammation in rats

    Drug Development Research, Vol. 70, Núm. 6, pp. 425-437

2007

  1. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis

    International Immunopharmacology, Vol. 7, Núm. 3, pp. 333-342